tirzepatide is insulin or not for diabetes: on track to SURPASS current therapy Shifting the Scales: Tirzepatide's Breakthrough

You're over 40

Wegovy is a once-weekly injectable weight loss medication containing semaglutide, a GLP-1 receptor agonist approved for chronic weight management

These factors, in addition to the necessity for regular monitoring and individualized adjustments, make it difficult to incorporate TZP into routine clinical practice, particularly for patients with limited financial resources or those experiencing adverse reactions

How To Choose (Personas) Choosing between semaglutide and tirzepatide is a decision you should make with your doctor

By helping regulate appetite, improve metabolic function, and encourage healthier habits, this therapy empowers you to achieve meaningful changes that endure